Nathan Piland

Nathan Piland, M.Eng, MBA, is an accomplished executive with extensive experience in the Medtech industry. Currently serving as Chief Executive Officer of Nunex and Head of Strategy, Growth & Ventures at Ciatrix, Nathan has made significant contributions to neurodegenerative disease research, particularly in dementia. As the founder of Strategies for Medtech, Nathan specializes in developing tailored strategies for Medtech companies and has held leadership roles at various organizations, including Indegene and RQM+, where Nathan successfully optimized growth strategies and improved business performance. Nathan's prior experience at Medtronic encompassed regulatory compliance, new product development, and project management, leading innovative advancements such as the Evolut PRO TAVR platform. Nathan holds a Master of Business Administration from Babson College and a Master of Engineering from Tufts University, backed by a Bachelor of Science in Mechanical Engineering from Wentworth Institute of Technology.